HFM
SNOA icon

Hartford Financial Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Hartford Financial Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3
Closed -$1K – 405
2018
Q3 		$1K Hold
3
– – ﹤0.01% 401
2018
Q2 		$1K Hold
3
– – ﹤0.01% 400
2018
Q1 		$1K Hold
3
– – ﹤0.01% 340
2017
Q4 		$2K Hold
3
– – ﹤0.01% 323
2017
Q3 		$2K Sell
3
-2
-40% -$2.17K ﹤0.01% 368
2017
Q2 		$5K Hold
5
– – ﹤0.01% 317
2017
Q1 		$6K Hold
5
– – ﹤0.01% 292
2016
Q4 		$5K Buy
+5
New +$4.14K ﹤0.01% 278

Other funds holding SNOA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return

Hartford Financial Management's SNOA Position: Q4 2018 in Review

Hartford Financial Management sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2018, closing a stake of 3 shares — an estimated $1K sold.

Hartford Financial Management first reported a position in SNOA in Q4 2016 and held it in 8 quarters. The position peaked at $6K in Q1 2017. 18 funds tracked by Wall St. Rank hold SNOA as of Q4 2018.

  • Hartford Financial Management reported no remaining Sonoma Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Hartford Financial Management sold 3 Sonoma Pharmaceuticals shares in Q4 2018, an estimated $1K.
  • Hartford Financial Management first reported a position in Sonoma Pharmaceuticals in Q4 2016 and held it in 8 quarters.
  • Hartford Financial Management's Sonoma Pharmaceuticals position peaked at $6K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2018.

Based on Hartford Financial Management's 13F filing for Q4 2018, filed 4 Feb 2019.